UCLA stem cell scientist and anti-bullying advocate featured on ESPN – UCLA Newsroom
|
UCLA stem cell scientist and anti-bullying advocate featured on ESPN
UCLA Newsroom UCLA stem cell researcher Andrew Goldstein was eating lunch in Westwood Village last March when he received an email on his phone with the subject line “Hoping you can help us out …” It was from the father of a lacrosse-obsessed 12-year-old boy who … |
Express.co.uk |
EXCLUSIVE: Stem cell therapy will be available within five years
Express.co.uk It is our strong belief that stem cell treatment will offer hope for millions of people.” Professor Barry, a world expert on stem cells at the National University of Ireland in Galway, will publish his results next month. Osteoarthritis affects 14 per … |
Express.co.uk |
EXCLUSIVE: Stem cell therapy will be available within five years
Express.co.uk It is our strong belief that stem cell treatment will offer hope for millions of people.” Professor Barry, a world expert on stem cells at the National University of Ireland in Galway, will publish his results next month. Osteoarthritis affects 14 per … |
|
Pivoting from photos to stem cells, Fujifilm finds a second life
Chicago Tribune Komori is no scientist, but the image embodies the Japanese brand’s shift away from photo-film and to new science and technology markets: Ebola drugs, anti-aging lotions and stem cell research. Over the last decade, Komori diversified into new … |
BioEdge |
Scepticism greets new stem–cell regulations in China
BioEdge China’s National Health and Family Planning Commission says that all stem cell treatments are deemed to be experimental, except for bone marrow transplants. There must be informed consent by the patient, clinical-grade stem cells must be used … |
BioEdge |
Scepticism greets new stem–cell regulations in China
BioEdge China’s National Health and Family Planning Commission says that all stem cell treatments are deemed to be experimental, except for bone marrow transplants. There must be informed consent by the patient, clinical-grade stem cells must be used … |
Boston Business Journal (blog) |
Waltham biotech to start selling ‘breakthrough’ stem cells after license deal
Boston Business Journal (blog) A Waltham developer of stem cell technologies, Minerva Biotechnologies, will begin selling what it calls “breakthrough” stem cells to researchers and biotechnology companies thanks to two recent licensing agreements with Japanese companies. The deal … |